Table 5.
Long-term and oncologic outcomes
|
Ref.
|
Recurrence rate (%)
|
1-yr OS (%)
|
3-yr OS (%)
|
5-yr OS (%)
|
10-yr OS (%)
|
1-yr DFS (%)
|
3-yr DFS (%)
|
5-yr DFS (%)
|
1-yr RFS (%)
|
3-yr RFS (%)
|
5-yr RFS (%)
|
| LLR in general | |||||||||||
| Abu Hilal et al[71] | 16 (after median FU of 22 mo) | - | - | - | - | - | - | - | - | - | - |
| Allard et al[60] | - | - | 85 | 70 | - | - | 42 | 31 | - | - | - |
| Barkhatov et al[25] | - | - | - | 54 | - | - | - | - | - | - | - |
| Beard et al[43] | - | - | - | 60 | - | - | - | 44 | - | - | - |
| Beppu et al[72] | - | 96.3 | 84.2 | 70.1 | - | - | - | - | 70.7 | 54.5 | 53.4 |
| Berardi et al[73] | 56.9 (after median FU of 8.4 mo) | 94 | 74 | 54 | - | - | - | - | 66 | 46 | 37 |
| Castaing et al[32] | 57 (after median FU of 30 mo) | 97 | 82 | 64 | - | 70 | 47 | 35 | 65 | 30 | 30 |
| Cipriani et al[75] | 57.7 | 85.9 | 66.7 | - | - | - | - | - | 54.2 | 29.4 | - |
| Cipriani et al[29] | - | 90.8 | 76.8 | 64.3 | - | 68.5 | 44.1 | 35.8 | 60.5 | 30.4 | 23.7 |
| D’Hondt et al[76] | - | - | - | 65 | - | - | - | - | - | - | - |
| de’Angelis et al[44] | 44.2 (after mean FU of 58.6 ± 44.4 mo) | 96.1 | 80.7 | 73.1 | - | 75 | 28.8 | 21.1 | - | - | - |
| Eveno et al[78] | - | - | 71 | 70 | - | - | 34 | 27 | - | - | - |
| Guerron et al[50] | 35 (after median FU of 16 mo) | - | - | - | - | - | - | - | - | - | - |
| Hirokawa et al[79] | - | 100 | 88 | 88 | - | 61 | 41 | 41 | - | - | - |
| Iwahashi et al[81] | - | 100 | 84 | 42 | - | 57 | 14 | 14 | - | - | - |
| Karagkounis et al[46] | - | - | 76 | 62 | - | - | - | - | - | - | - |
| Kasai et al[82] | - | 100 | 85.4 | 68 | - | 55.7 | 30.4 | 30.4 | - | - | - |
| Kazaryan et al[26] | - | 84 | 69 | 47 | - | 63 | 45 | 42 | 44 | 24 | 24 |
| Kazaryan et al[83] | - | - | - | 46 | - | - | - | - | - | - | - |
| Kubota et al[51] | - | - | 88.4 | - | - | - | - | - | - | - | - |
| Langella et al[52] | 37.8 (after median FU of 35.7 ± 24.9 mo) | - | 91.8 | - | - | - | 69.1 | - | - | - | - |
| Lewin et al[84] | - | - | - | 54 | - | - | - | - | - | - | 36 |
| Martínez-Cecilia et al[30] | - | 93 | 68 | 43 | - | - | - | - | 71 | 43 | 31 |
| Nguyen et al[31] | - | 88 | 69 | 50 | - | 65 | 43 | 43 | - | - | - |
| Postriganova et al[28] | - | 84 | 64 | 49 | - | 61 | 45 | 41 | 48 | 35 | 33 |
| Postriganova et al[28] | 38.5 | - | - | - | - | - | - | - | - | - | - |
| Postriganova et al[28] | 67.7 (after median FU of 40 mo) | 92.5 | 71.5 | 49.3 | - | 72.7 | 33.5 | 22.7 | - | - | - |
| Postriganova et al[28] | - | - | - | - | - | 68.2 | 22.7 | 18.1 | - | - | - |
| Tabchouri et al[70] | 72 (after median FU of 16 mo) | - | 82 | 71 | 43 | - | - | - | - | - | - |
| Tohme et al[55] | - | - | 74.4 | 51.3 | - | - | - | - | - | - | - |
| Vibert et al[87] | - | 97 | 87 | - | - | 74 | 51 | - | - | - | - |
| Yue et al[39] | 52.5 (after FU of 31 mo) | - | - | 52 | - | - | - | 45 | - | - | - |
| Yun et al[88] | - | - | 95 | - | - | - | - | - | - | - | - |
| Andorra et al[89] | - | - | - | 43.5 | - | - | - | - | - | - | - |
| Major LLR | |||||||||||
| Nomi et al[57] | 67.7 (after median FU of 39 mo) | - | - | - | - | - | - | - | - | - | - |
| Topal et al[58] | - | 90 | - | 48 | - | 60 | - | 43 | - | - | - |
| Minor LLR | |||||||||||
| Vavra et al[63] | - | - | - | 82.1 | - | - | - | 63.2 | - | - | - |
| LLR of posterosuperior segments | |||||||||||
| Montalti et al[91] | - | 96.4 | 70.8 | 62.9 | - | - | - | - | 63.7 | 37.1 | 32.5 |
| Okuno et al[42] | - | 100 | - | - | - | - | - | - | 49.9 | - | - |
| Scuderi et al[93] | - | - | - | - | - | - | - | - | - | 36 | - |
| Efanov et al[94] | - | - | - | 60 | - | - | - | - | - | - | - |
| Parenchyma sparing LLR | |||||||||||
| Aghayan et al[47] | 64 (after median FU of 6 mo) | - | 68 | 48 | - | - | - | - | - | 36 | 34 |
| Montalti et al[33] | 57.9 (after mean follow-up of 30.9 mo ± 1.71) | 98 | 75 | 59 | - | - | - | - | 64.2 | 35.2 | 31 |
| Okumura et al[95] | 59.8 (after median FU of 33.9 mo) | - | 85.1 | - | - | - | - | - | - | 28.8 | - |
| Martínez-Cecilia et al[62] | - | 94 | 82 | 65 | - | - | - | - | 82 | 71 | 54 |
| Simultaneous laparoscopic colorectal and liver resection | |||||||||||
| Berti et al[40] | 60 (after median FU of 19 mo) | - | - | - | - | - | - | - | - | - | - |
| Dagher et al[61] | 28 (after median FU of 26 mo) | 97 | 78 | - | - | 79 | 64 | - | - | - | - |
| Ferretti et al[64] | 28.2 (after median FU of 29 mo) | 98.8 | 82.1 | 71.9 | - | 85.6 | 65.9 | 63 | - | - | - |
| Ratti et al[65] | 36 (after mean FU of 37 mo) | - | - | - | - | - | - | - | - | - | - |
| Shin et al[34] | - | - | 74.4 | - | - | - | 58.5 | - | - | 59.6 | - |
| Xu et al[35] | - | - | 51.3 | - | - | - | 31.6 | - | - | - | - |
| Two-stage hepatectomy | |||||||||||
| Okumura et al[59] | - | - | 80 | - | - | - | - | - | - | - | - |
| Repeat LLR | |||||||||||
| Nomi et al[36] | 77.8 (after a median FU of 43 mo) | - | - | 43.2 | - | - | - | - | - | - | - |
| Hallet et al[37] | 66.7 (after a median FU of 20.7 mo) | - | - | - | - | - | - | - | - | - | 21.4 |
DFS: Disease-free survival; FU: Follow-up; LLR: Laparoscopic liver resection; OS: Overall survival; RFS: Recurrence-free survival.